# HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study

> **NCT06798246** · — · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Upper Tract Urothelial Carcinoma

## Interventions

- **DRUG:** Chemotherapy
- **DRUG:** Immunotherapy
- **DRUG:** ADC
- **DRUG:** Chemotherapy combined with immunotherapy

## Key facts

- **NCT ID:** NCT06798246
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-01-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798246, "HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06798246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*